Brief
Researchers aim to create exercise‑mimicking drugs, but face regulatory and scientific hurdles
Scientists are developing compounds that trigger exercise‑related pathways, yet safety, efficacy and regulatory approval remain major obstacles.
By Felo News Desk · Published
Researchers are working on medicines that could reproduce some health benefits of physical activity, targeting people with frailty, disability or chronic disease, Technology Review reported.
The effort focuses on identifying the cascade of hormones, enzymes and molecular signals activated by movement. One target is a muscle‑cell receptor that stays switched on without exercise; mice given a drug that amplifies this receptor ran longer and farther, becoming “marathon mice” without training, according to pharmacologist Thomas Burris of the University of Florida.
Burris, who founded the biotech firm Pelagos, says the compound also showed early signs of improving cognition and treating heart failure in animal studies. Similar approaches have entered human trials: Cambrian Bio announced that its experimental drug ATX‑304 boosted metabolism and cut liver and belly fat in participants with obesity and pre‑diabetes, acting on a metabolic switch that senses low energy supplies.
Despite promising pre‑clinical data, more than 90 % of treatments that reach human studies fail, and the FDA typically approves drugs for disease treatment rather than wellness enhancement, Burris noted. Doping authorities have already banned some of these experimental compounds, highlighting regulatory scrutiny.
Key facts
- Scientists are targeting exercise‑related molecular pathways to develop mimicking drugs. (technologyreview.com)
- Thomas Burris's lab created a compound that activates a muscle‑cell receptor, improving endurance in mice. (technologyreview.com)
- Cambrian Bio's ATX‑304 showed metabolic benefits in obese and pre‑diabetic participants. (technologyreview.com)
- Over 90 % of treatments entering human trials fail, and the FDA focuses on disease‑treating drugs. (technologyreview.com)
Sources
- [1] technologyreview.com — originally reported as “Exercise in a pill”
